These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 29970665)
1. Expression of fascin_1 protein in cancer tissues of patients with nonsmall cell lung cancer and its relevance to patients' clinicopathologic features and prognosis. Zhang Y; Liang B; Dong H J Cancer Res Ther; 2018; 14(4):856-859. PubMed ID: 29970665 [TBL] [Abstract][Full Text] [Related]
2. Leucine-rich repeats and immunoglobulin-like domains protein 1 and fascin actin-bundling protein 1 expression in nonsmall cell lung cancer. Zhang J; Wang X; Zhang Y; Wu J; Zhou N J Cancer Res Ther; 2016 Dec; 12(Supplement):C248-C251. PubMed ID: 28230028 [TBL] [Abstract][Full Text] [Related]
3. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Pelosi G; Pastorino U; Pasini F; Maissoneuve P; Fraggetta F; Iannucci A; Sonzogni A; De Manzoni G; Terzi A; Durante E; Bresaola E; Pezzella F; Viale G Br J Cancer; 2003 Feb; 88(4):537-47. PubMed ID: 12592367 [TBL] [Abstract][Full Text] [Related]
4. Correlations of fascin-1 and cadherin-17 protein expression with clinicopathologic features and prognosis of patients with gastric cancer. Tu L; Xu J; Wang M; Zhao WY; Zhang ZZ; Zhu CC; Tang DF; Zhang YQ; Wang DH; Zuo J; Cao H Tumour Biol; 2016 Jul; 37(7):8775-82. PubMed ID: 26743780 [TBL] [Abstract][Full Text] [Related]
5. Serological investigation of the clinical significance of fascin in non-small-cell lung cancer. Teng Y; Xu S; Yue W; Ma L; Zhang L; Zhao X; Guo Y; Zhang C; Gu M; Wang Y Lung Cancer; 2013 Nov; 82(2):346-52. PubMed ID: 24070574 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of fascin-1 expression suppresses cell migration and invasion of non-small cell lung cancer by regulating the MAPK pathway. Zhao D; Zhang T; Hou XM; Ling XL Biochem Biophys Res Commun; 2018 Mar; 497(2):694-699. PubMed ID: 29458026 [TBL] [Abstract][Full Text] [Related]
7. Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling. Liang Z; Wang Y; Shen Z; Teng X; Li X; Li C; Wu W; Zhou Z; Wang Z Tumour Biol; 2016 Aug; 37(8):10909-15. PubMed ID: 26886283 [TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of fascin-1 and laminin-5 in non-small cell lung cancer. Yang L; Teng Y; Han TP; Li FG; Yue WT; Wang ZT Genet Mol Res; 2017 Jun; 16(2):. PubMed ID: 28653739 [TBL] [Abstract][Full Text] [Related]
10. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer. Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873 [TBL] [Abstract][Full Text] [Related]
11. Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients: A cohort study. Yang XY; Zhang J; Yu XL; Zheng GF; Zhao F; Jia XJ J Cancer Res Ther; 2018; 14(Supplement):S65-S71. PubMed ID: 29578152 [TBL] [Abstract][Full Text] [Related]
12. Combined Fascin-1 and MAP17 Expression in Breast Cancer Identifies Patients with High Risk for Disease Recurrence. Tampaki EC; Tampakis A; Nonni A; von Flüe M; Patsouris E; Kontzoglou K; Kouraklis G Mol Diagn Ther; 2019 Oct; 23(5):635-644. PubMed ID: 31273628 [TBL] [Abstract][Full Text] [Related]
13. Protein Kinase D1 Is Increased in Tumor Tissue, Correlates With Advanced Tumor Features and Worse Prognosis of Non-Small Cell Lung Cancer. Yao J; Jiang Y; Geng S; Sun L Technol Cancer Res Treat; 2020; 19():1533033820934129. PubMed ID: 32985371 [TBL] [Abstract][Full Text] [Related]
14. [Expression of Fascin-1 protein in breast cancer and its clinicopathologic correlation]. Wang C; Huang B; Wu Z; Sun X; Zeng Y; Wang Y Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):451-4. PubMed ID: 25327793 [TBL] [Abstract][Full Text] [Related]
15. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer. Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
17. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance]. Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of sphingosine kinase 2 expression in non-small cell lung cancer. Wang Q; Li J; Li G; Li Y; Xu C; Li M; Xu G; Fu S Tumour Biol; 2014 Jan; 35(1):363-8. PubMed ID: 23918304 [TBL] [Abstract][Full Text] [Related]
19. [Expression of fascin in human esophageal squamous cell carcinoma and its clinical significance]. Qin YR; Tang H; Qiao JJ; Li FF; Ai JY Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1216-9. PubMed ID: 21764699 [TBL] [Abstract][Full Text] [Related]
20. Expression of Fascin-1 on human lung cancer and paracarcinoma tissue and its relation to clinicopathological characteristics in patients with lung cancer. Zhao W; Gao J; Wu J; Liu QH; Wang ZG; Li HL; Xing LH Onco Targets Ther; 2015; 8():2571-6. PubMed ID: 26451116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]